At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD III study, the largest and most rigorous coronary IVL study to date.
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD III study, the largest and most rigorous coronary IVL study to date.
Topics: Coronary IVL, Coronary Clinical Data
Perspective on IVL-Induced Ventricular Capture from Keith D. Dawkins, M.D., Chief Medical Officer, Shockwave Medical, Inc.:
Topics: Coronary IVL, Coronary Clinical Data
Following its presentation as a late-breaking clinical at TCT Connect and simultaneous publication in the Journal of the American College of Cardiology (JACC) we sat down with Dr. Jonathan Hill, Consultant Cardiologist at the Royal Brompton Hospital in London, to get his perspective on the results, how they build on CAD I & II outcomes, and where they fit into clinician’s daily decision-making process when treating calcified lesions. We hope you enjoy his perspective.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2, Coronary Conferences
Last month the DISRUPT CAD III investigators, led by co-PIs Drs. Dean Kereiakes and Jonathan Hill, published in the American Heart Journal the trial design and rationale paper titled, “Evaluation of safety and efficacy of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: Design and rationale for the Disrupt CAD III trial.”
Topics: Coronary IVL, Coronary Clinical Data
No one likes to be stuck between a rock and hard place…well, in interventional cardiology, no one likes to treat a rock in a hard place either! Calcified bifurcations are one of the most complex clinical scenarios faced today on a routine basis. For that reason, we’ve paired up a few international “rockstar” physicians to give you the 101 on calcified bifurcations whether you’re 1,1,1 1,0,1 or 0,1,0…
Topics: Coronary IVL
Prof. Carlo Di Mario, Director of Structural Interventional Cardiology at the Careggi University Hospital in Florence, Italy, and other cardiologists in Florence recently published their initial real-world experience when using intravascular imaging while treating coronary lesions with Intravascular Lithotripsy (IVL).
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2, Treating Different Ca++ Morphologies
In case you weren’t able to make it to EuroPCR’s e-Course last week, you missed a great discussion among some of coronary IVL’s most knowledgeable operators about how they’re using the technology in the real-world setting. Lucky for you, we’ve included the sponsored roundtable discussion below featuring Drs. Benjamin Honton (FR), Javier Escaned (ES) and Michael Lee (HK). We hope you enjoy hearing their perspectives from across Europe and Asia.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2, Coronary Conferences
Recently, Dr. James Spratt, consultant cardiologist at St George's University NHS Trust in London and founder of Optima Education, and other leading UK cardiologists published their experience with Intravascular Lithotripsy (IVL) in the left main in EuroIntervention: Intravascular lithotripsy for the treatment of calcific distal left main disease.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2
Last month, we had the pleasure of being hosted by Prof. Holger Nef from Giessen, Germany, and Dr. Nikos Werner at his cath lab in Trier, Germany, for a day of cases followed by a live webinar with InCathLab.
Topics: Coronary IVL, Shockwave C2
Recently, Dr. Stefan Harb partnered with Drs. Patrick Siegrist and Tim Schäufele to host the first ever IVL workshop in the DACH region at LKH Graz II Standort West in Graz, Austria. We asked Stefan to relay some of his key takeaways during the workshop and some of the more interesting discussions for the benefit of IVL users across the EU. We hope you enjoy his recap:
Topics: Coronary IVL, IVL Technology, Shockwave C2